Induced regulatory T cells: mechanisms of conversion and suppressive potential

被引:54
作者
Dons, Eefje M. [1 ,2 ]
Raimondi, Giorgio [1 ]
Cooper, David K. C. [1 ]
Thomson, Angus W. [1 ,3 ]
机构
[1] Univ Pittsburgh, Dept Surg, Thomas E Starzl Transplantat Inst, Pittsburgh, PA 15261 USA
[2] Erasmus MC, Dept Surg, NL-3013 CE Rotterdam, Netherlands
[3] Univ Pittsburgh, Dept Immunol, Pittsburgh, PA 15261 USA
基金
美国国家卫生研究院;
关键词
Naturally occurring regulatory T cells; Induced regulatory T cells; Immune suppression; Tolerance; Transplantation; DE-NOVO GENERATION; GROWTH-FACTOR-BETA; TGF-BETA; DENDRITIC CELLS; RETINOIC-ACID; CUTTING EDGE; TH17; CELLS; INFECTIOUS TOLERANCE; EX-VIVO; RAPAMYCIN PROMOTES;
D O I
10.1016/j.humimm.2011.12.011
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
071005 [微生物学]; 100108 [医学免疫学];
摘要
Thymus-derived, naturally occurring CD4(+) Forkhead Box P3(+) regulatory T cells (nTreg) have suppressive activity that is important for the establishment and maintenance of immune homeostasis in the healthy state. Abundant reports have demonstrated that they can suppress pathogenic processes in autoimmune diseases and inhibit transplant rejection and graft-versus-host disease. Far less is known about induced regulatory T cells (iTreg) that are generated from naive T cells in the periphery or in vitro by directing naive T cells to acquire suppressive function under the influence of transforming growth factor-beta and other factors. In this review, we describe mechanisms by which naive T cells are thought to be converted into iTreg. we also discuss the suppressive potential of iTreg, particularly in comparison with their naturally occurring counterparts, focusing on those reports in which direct comparisons have been made. Based on current knowledge, we consider the rationale for using iTreg versus nTreg in clinical trials. (C) 2012 Published by Elsevier Inc. on behalf of American Society for Histocompatibility and Immunogenetics.
引用
收藏
页码:328 / 334
页数:7
相关论文
共 92 条
[1]
Interleukins 1β and 6 but not transforming growth factor-β are essential for the differentiation of interleukin 17-producing human T helper cells [J].
Acosta-Rodriguez, Eva V. ;
Napolitani, Giorgio ;
Lanzavecchia, Antonio ;
Sallusto, Federica .
NATURE IMMUNOLOGY, 2007, 8 (09) :942-949
[2]
Generation of potent and stable human CD4+ T regulatory cells by activation-independent expression of FOXP3 [J].
Allan, Sarah E. ;
Alstad, Alicia N. ;
Merindol, Natacha ;
Crellin, Natasha K. ;
Amendola, Mario ;
Bacchetta, Rosa ;
Naldini, Luigi ;
Roncarolo, Maria Grazia ;
Soudeyns, Hugo ;
Levings, Megan K. .
MOLECULAR THERAPY, 2008, 16 (01) :194-202
[3]
The role of 2 FOXP3 isoforms in the generation of human CD4+ Tregs [J].
Allan, SE ;
Passerini, L ;
Bacchetta, R ;
Crellin, N ;
Dai, MY ;
Orban, PC ;
Ziegler, SF ;
Roncarolo, MG ;
Levings, MK .
JOURNAL OF CLINICAL INVESTIGATION, 2005, 115 (11) :3276-3284
[4]
Rapamycin promotes expansion of functional CD4+CD25+FOXP3+ regulatory T cells of both healthy subjects and type 1 diabetic patients [J].
Battaglia, Manuela ;
Stabilini, Angela ;
Migliavacca, Barbara ;
Horejs-Hoeck, Jutta ;
Kaupper, Thomas ;
Roncarolo, Maria-Grazia .
JOURNAL OF IMMUNOLOGY, 2006, 177 (12) :8338-8347
[5]
TGF-β-dependent mechanisms mediate restoration of self-tolerance induced by antibodies to CD3 in overt autoimmune diabetes [J].
Belghith, M ;
Bluestone, JA ;
Barriot, S ;
Mégret, J ;
Bach, JF ;
Chatenoud, L .
NATURE MEDICINE, 2003, 9 (09) :1202-1208
[6]
All-trans retinoic acid mediates enhanced T reg cell growth, differentiation, and gut homing in the face of high levels of co-stimulation [J].
Benson, Micah J. ;
Pino-Lagos, Karina ;
Rosemblatt, Mario ;
Noelle, Randolph J. .
JOURNAL OF EXPERIMENTAL MEDICINE, 2007, 204 (08) :1765-1774
[7]
ALPHA-4-BETA-7-INTEGRIN MEDIATES LYMPHOCYTE BINDING TO THE MUCOSAL VASCULAR ADDRESSIN MADCAM-1 [J].
BERLIN, C ;
BERG, EL ;
BRISKIN, MJ ;
ANDREW, DP ;
KILSHAW, PJ ;
HOLZMANN, B ;
WEISSMAN, IL ;
HAMANN, A ;
BUTCHER, EC .
CELL, 1993, 74 (01) :185-195
[8]
Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells [J].
Bettelli, E ;
Carrier, YJ ;
Gao, WD ;
Korn, T ;
Strom, TB ;
Oukka, M ;
Weiner, HL ;
Kuchroo, VK .
NATURE, 2006, 441 (7090) :235-238
[9]
CD4+CD25+FOXP3+ regulatory t cells increase De novo in kidney transplant patients after immunodepletion with Campath-1H [J].
Bloom, D. D. ;
Chang, Z. ;
Fechner, J. H. ;
Dar, W. ;
Polster, S. P. ;
Pascual, J. ;
Turka, L. A. ;
Knechtle, S. J. .
AMERICAN JOURNAL OF TRANSPLANTATION, 2008, 8 (04) :793-802
[10]
Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics [J].
Brunstein, Claudio G. ;
Miller, Jeffrey S. ;
Cao, Qing ;
McKenna, David H. ;
Hippen, Keli L. ;
Curtsinger, Julie ;
DeFor, Todd ;
Levine, Bruce L. ;
June, Carl H. ;
Rubinstein, Pablo ;
McGlave, Philip B. ;
Blazar, Bruce R. ;
Wagner, John E. .
BLOOD, 2011, 117 (03) :1061-1070